Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET/MRI Evaluation of Endometriosis Using Intercellular Matrix Radiopharmaceuticals

NCT06377553 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06377553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06377553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET/MRI Evaluation of Endometriosis Using Intercellular Matrix Radiopharmaceuticals
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 6, 2025
Completion date
May 3, 2029
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrioma, endometriosis